HEADER VIRAL PROTEIN 11-AUG-00 1FL1 TITLE KSHV PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 8; SOURCE 3 ORGANISM_TAXID: 37296; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PQE30 KEYWDS SERINE PROTEASE, ANTIVIRAL DRUG DESIGN, CAPSID MATURATION, KEYWDS 2 ENDOPEPTIDASE, ASSEMBLIN, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.K.REILING,T.R.PRAY,C.S.CRAIK,R.M.STROUD REVDAT 6 07-FEB-24 1FL1 1 REMARK REVDAT 5 03-NOV-21 1FL1 1 REMARK SEQADV LINK REVDAT 4 31-JAN-18 1FL1 1 REMARK REVDAT 3 04-OCT-17 1FL1 1 REMARK REVDAT 2 24-FEB-09 1FL1 1 VERSN REVDAT 1 22-NOV-00 1FL1 0 JRNL AUTH K.K.REILING,T.R.PRAY,C.S.CRAIK,R.M.STROUD JRNL TITL FUNCTIONAL CONSEQUENCES OF THE KAPOSI'S SARCOMA-ASSOCIATED JRNL TITL 2 HERPESVIRUS PROTEASE STRUCTURE: REGULATION OF ACTIVITY AND JRNL TITL 3 DIMERIZATION BY CONSERVED STRUCTURAL ELEMENTS. JRNL REF BIOCHEMISTRY V. 39 12796 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 11041844 JRNL DOI 10.1021/BI001019H REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.T.BRUNGER,P.D.ADAMS,G.M.CLORE,W.L.DELANO,P.GROS, REMARK 1 AUTH 2 R.GROSSE-KUNSTLEVE,J.-S.JIANG,J.KUSZEWSKI,M.NILGES, REMARK 1 AUTH 3 N.S.PANNU,R.J.READ,L.M.RICE,T.SIMONSON,G.WARREN REMARK 1 TITL CRYSTALLOGRAPHY & NMR SYSTEM: A NEW SOFTWARE SUITE FOR REMARK 1 TITL 2 MACROMOLECULAR STRUCTURE DETERMINATION REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 905 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444998003254 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : CAMBRIDGE DATA BASE MODEL STRUCTURES (R. A. REMARK 3 ENGH AND R. HUBER, ACTA CRYST. SECT. A., 1991) REMARK 3 . REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 27951 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1642 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2987 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 169 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.561 REMARK 3 BOND ANGLES (DEGREES) : 3.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES 182 AND 207 HAD DENSITY ONLY TO THE CG REMARK 3 AND WERE MODELED AS SERINES DURING REFINEMENT. REMARK 4 REMARK 4 1FL1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-00. REMARK 100 THE DEPOSITION ID IS D_1000011677. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28034 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 28.282 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG-2K, 100 MM TRIS-HCL, 10% REMARK 280 GLYCEROL, 190 MM LISO4, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 25K, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 107.68667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 215.37333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 215.37333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 107.68667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ACTIVE ENZYME IS A HOMO-DIMER CONSTRUCTED REMARK 300 FROM CHAIN A AND B RELATED BY A NON-CRYSTALOGRAPHIC TWO-FOLD. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 80.37000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 46.40164 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 107.68667 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 CYS A 16 REMARK 465 PRO A 17 REMARK 465 LYS A 18 REMARK 465 LEU A 19 REMARK 465 GLU A 20 REMARK 465 GLN A 21 REMARK 465 GLU A 22 REMARK 465 LEU A 23 REMARK 465 TYR A 24 REMARK 465 LEU A 25 REMARK 465 ASP A 26 REMARK 465 PRO A 27 REMARK 465 ASP A 28 REMARK 465 GLN A 29 REMARK 465 VAL A 30 REMARK 465 THR A 31 REMARK 465 ASP A 32 REMARK 465 TYR A 33 REMARK 465 LEU A 34 REMARK 465 PRO A 35 REMARK 465 VAL A 36 REMARK 465 THR A 37 REMARK 465 SER A 117 REMARK 465 ILE A 118 REMARK 465 HIS A 119 REMARK 465 PRO A 120 REMARK 465 ARG A 121 REMARK 465 GLU A 122 REMARK 465 LEU A 123 REMARK 465 SER A 124 REMARK 465 GLN A 125 REMARK 465 THR A 126 REMARK 465 PRO A 127 REMARK 465 SER A 128 REMARK 465 GLY A 129 REMARK 465 PRO A 130 REMARK 465 VAL A 131 REMARK 465 MET B 1 REMARK 465 SER B 15 REMARK 465 CYS B 16 REMARK 465 PRO B 17 REMARK 465 LYS B 18 REMARK 465 LEU B 19 REMARK 465 GLU B 20 REMARK 465 GLN B 21 REMARK 465 GLU B 22 REMARK 465 LEU B 23 REMARK 465 TYR B 24 REMARK 465 LEU B 25 REMARK 465 ASP B 26 REMARK 465 PRO B 27 REMARK 465 ARG B 121 REMARK 465 GLU B 122 REMARK 465 LEU B 123 REMARK 465 SER B 124 REMARK 465 GLN B 125 REMARK 465 THR B 126 REMARK 465 PRO B 127 REMARK 465 SER B 128 REMARK 465 GLY B 129 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 14 CG1 CG2 REMARK 470 SER A 15 OG REMARK 470 GLU A 38 CG CD OE1 OE2 REMARK 470 GLU A 78 CG CD OE1 OE2 REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 ARG A 142 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 182 CG CD OE1 OE2 REMARK 470 ASP A 183 CG OD1 OD2 REMARK 470 ARG A 207 CG CD NE CZ NH1 NH2 REMARK 470 ALA B 2 CB REMARK 470 ASP B 28 CG OD1 OD2 REMARK 470 THR B 31 OG1 CG2 REMARK 470 GLU B 78 CG CD OE1 OE2 REMARK 470 ARG B 91 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 HIS B 119 CB CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 143 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 182 CD OE1 OE2 REMARK 470 ARG B 207 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 K K B 1001 K K B 1001 6765 0.96 REMARK 500 O HOH A 290 O HOH A 290 5555 2.04 REMARK 500 O HOH B 1064 O HOH B 1064 6765 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS B 119 C - N - CA ANGL. DEV. = -19.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 3 -74.49 -94.15 REMARK 500 LYS A 95 -88.40 -105.68 REMARK 500 THR A 146 33.80 -91.42 REMARK 500 GLU A 182 36.51 -67.33 REMARK 500 ASP A 183 15.49 -156.54 REMARK 500 ASP B 32 -5.03 -173.36 REMARK 500 LYS B 95 -89.37 -103.75 REMARK 500 THR B 146 39.61 -96.81 REMARK 500 SER B 191 140.55 -38.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K B1001 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 171 NE2 REMARK 620 2 HIS B 171 NE2 78.7 REMARK 620 3 HIS B 175 NE2 110.3 133.3 REMARK 620 4 HIS B 175 NE2 97.3 95.0 127.1 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K B 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AT3 RELATED DB: PDB REMARK 900 HERPES SIMPLEX VIRUS TYPE II PROTEASE REMARK 900 RELATED ID: 1VZV RELATED DB: PDB REMARK 900 VARICELLA-ZOSTER VIRUS PROTEASE REMARK 900 RELATED ID: 1CMV RELATED DB: PDB REMARK 900 HUMAN CYTOMEGALOVIRUS PROTEASE REMARK 900 RELATED ID: 1WPO RELATED DB: PDB REMARK 900 HUMAN CYTOMEGALOVIRUS PROTEASE - INHIBITED REMARK 900 RELATED ID: 1LAY RELATED DB: PDB REMARK 900 HUMAN CYTOMEGALOVIRUS PROTEASE DBREF 1FL1 A 1 230 UNP O36607 O36607_HHV8 1 230 DBREF 1FL1 B 1 230 UNP O36607 O36607_HHV8 1 230 SEQADV 1FL1 GLY A 204 UNP O36607 SER 204 ENGINEERED MUTATION SEQADV 1FL1 GLY B 204 UNP O36607 SER 204 ENGINEERED MUTATION SEQRES 1 A 230 MET ALA GLN GLY LEU TYR VAL GLY GLY PHE VAL ASP VAL SEQRES 2 A 230 VAL SER CYS PRO LYS LEU GLU GLN GLU LEU TYR LEU ASP SEQRES 3 A 230 PRO ASP GLN VAL THR ASP TYR LEU PRO VAL THR GLU PRO SEQRES 4 A 230 LEU PRO ILE THR ILE GLU HIS LEU PRO GLU THR GLU VAL SEQRES 5 A 230 GLY TRP THR LEU GLY LEU PHE GLN VAL SER HIS GLY ILE SEQRES 6 A 230 PHE CYS THR GLY ALA ILE THR SER PRO ALA PHE LEU GLU SEQRES 7 A 230 LEU ALA SER ARG LEU ALA ASP THR SER HIS VAL ALA ARG SEQRES 8 A 230 ALA PRO VAL LYS ASN LEU PRO LYS GLU PRO LEU LEU GLU SEQRES 9 A 230 ILE LEU HIS THR TRP LEU PRO GLY LEU SER LEU SER SER SEQRES 10 A 230 ILE HIS PRO ARG GLU LEU SER GLN THR PRO SER GLY PRO SEQRES 11 A 230 VAL PHE GLN HIS VAL SER LEU CYS ALA LEU GLY ARG ARG SEQRES 12 A 230 ARG GLY THR VAL ALA VAL TYR GLY HIS ASP ALA GLU TRP SEQRES 13 A 230 VAL VAL SER ARG PHE SER SER VAL SER LYS SER GLU ARG SEQRES 14 A 230 ALA HIS ILE LEU GLN HIS VAL SER SER CYS ARG LEU GLU SEQRES 15 A 230 ASP LEU SER THR PRO ASN PHE VAL SER PRO LEU GLU THR SEQRES 16 A 230 LEU MET ALA LYS ALA ILE ASP ALA GLY PHE ILE ARG ASP SEQRES 17 A 230 ARG LEU ASP LEU LEU LYS THR ASP ARG GLY VAL ALA SER SEQRES 18 A 230 ILE LEU SER PRO VAL TYR LEU LYS ALA SEQRES 1 B 230 MET ALA GLN GLY LEU TYR VAL GLY GLY PHE VAL ASP VAL SEQRES 2 B 230 VAL SER CYS PRO LYS LEU GLU GLN GLU LEU TYR LEU ASP SEQRES 3 B 230 PRO ASP GLN VAL THR ASP TYR LEU PRO VAL THR GLU PRO SEQRES 4 B 230 LEU PRO ILE THR ILE GLU HIS LEU PRO GLU THR GLU VAL SEQRES 5 B 230 GLY TRP THR LEU GLY LEU PHE GLN VAL SER HIS GLY ILE SEQRES 6 B 230 PHE CYS THR GLY ALA ILE THR SER PRO ALA PHE LEU GLU SEQRES 7 B 230 LEU ALA SER ARG LEU ALA ASP THR SER HIS VAL ALA ARG SEQRES 8 B 230 ALA PRO VAL LYS ASN LEU PRO LYS GLU PRO LEU LEU GLU SEQRES 9 B 230 ILE LEU HIS THR TRP LEU PRO GLY LEU SER LEU SER SER SEQRES 10 B 230 ILE HIS PRO ARG GLU LEU SER GLN THR PRO SER GLY PRO SEQRES 11 B 230 VAL PHE GLN HIS VAL SER LEU CYS ALA LEU GLY ARG ARG SEQRES 12 B 230 ARG GLY THR VAL ALA VAL TYR GLY HIS ASP ALA GLU TRP SEQRES 13 B 230 VAL VAL SER ARG PHE SER SER VAL SER LYS SER GLU ARG SEQRES 14 B 230 ALA HIS ILE LEU GLN HIS VAL SER SER CYS ARG LEU GLU SEQRES 15 B 230 ASP LEU SER THR PRO ASN PHE VAL SER PRO LEU GLU THR SEQRES 16 B 230 LEU MET ALA LYS ALA ILE ASP ALA GLY PHE ILE ARG ASP SEQRES 17 B 230 ARG LEU ASP LEU LEU LYS THR ASP ARG GLY VAL ALA SER SEQRES 18 B 230 ILE LEU SER PRO VAL TYR LEU LYS ALA HET K B1001 1 HETNAM K POTASSIUM ION FORMUL 3 K K 1+ FORMUL 4 HOH *169(H2 O) HELIX 1 1 SER A 73 SER A 87 1 15 HELIX 2 2 HIS A 88 ARG A 91 5 4 HELIX 3 3 GLU A 100 LEU A 110 1 11 HELIX 4 4 ASP A 153 ARG A 160 1 8 HELIX 5 5 SER A 165 SER A 178 1 14 HELIX 6 6 PRO A 192 GLY A 204 1 13 HELIX 7 7 ASP A 208 SER A 221 1 14 HELIX 8 8 SER B 73 SER B 87 1 15 HELIX 9 9 HIS B 88 ARG B 91 5 4 HELIX 10 10 GLU B 100 LEU B 110 1 11 HELIX 11 11 ASP B 153 ARG B 160 1 8 HELIX 12 12 SER B 165 SER B 178 1 14 HELIX 13 13 ARG B 180 LEU B 184 5 5 HELIX 14 14 PRO B 192 GLY B 204 1 13 HELIX 15 15 ASP B 208 ALA B 220 1 13 SHEET 1 A 7 GLY A 112 LEU A 115 0 SHEET 2 A 7 VAL A 135 CYS A 138 -1 N SER A 136 O SER A 114 SHEET 3 A 7 PRO A 41 ILE A 44 1 O PRO A 41 N VAL A 135 SHEET 4 A 7 GLY A 53 VAL A 61 -1 O GLY A 53 N ILE A 42 SHEET 5 A 7 GLY A 64 ILE A 71 -1 O GLY A 64 N VAL A 61 SHEET 6 A 7 LEU A 5 ASP A 12 -1 O LEU A 5 N ILE A 71 SHEET 7 A 7 VAL A 149 GLY A 151 -1 N VAL A 149 O GLY A 8 SHEET 1 B 7 GLY B 112 SER B 117 0 SHEET 2 B 7 PHE B 132 CYS B 138 -1 N GLN B 133 O SER B 116 SHEET 3 B 7 PRO B 41 ILE B 44 1 O PRO B 41 N VAL B 135 SHEET 4 B 7 GLY B 53 VAL B 61 -1 O GLY B 53 N ILE B 42 SHEET 5 B 7 GLY B 64 ILE B 71 -1 O GLY B 64 N VAL B 61 SHEET 6 B 7 LEU B 5 VAL B 13 -1 O LEU B 5 N ILE B 71 SHEET 7 B 7 VAL B 149 GLY B 151 -1 N VAL B 149 O GLY B 8 LINK NE2 HIS B 171 K K B1001 1555 1555 2.42 LINK NE2 HIS B 171 K K B1001 6765 1555 2.16 LINK NE2 HIS B 175 K K B1001 1555 1555 2.38 LINK NE2 HIS B 175 K K B1001 6765 1555 3.11 CISPEP 1 SER A 224 PRO A 225 0 -0.43 CISPEP 2 LEU B 34 PRO B 35 0 -0.33 CISPEP 3 SER B 224 PRO B 225 0 0.08 SITE 1 AC1 2 HIS B 171 HIS B 175 CRYST1 53.580 53.580 323.060 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018664 0.010775 0.000000 0.00000 SCALE2 0.000000 0.021551 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003095 0.00000